Page 6 - Neurodegenerative Disease Program Progress News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Neurodegenerative disease program progress. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Neurodegenerative Disease Program Progress Today - Breaking & Trending Today

PARIS, France, May 22th, 2023, 08:30 am CET – Pharnext SCA , an advanced late-clinical stage biopharmaceutical company developing novel therapeutics for neurodegenerative diseases with high. | May 22, 2023 ....

United States , France General , Hugo Brugi , Fabreguettes Leib , Edison Group , Edison Investment Research , January Neovacs , Euronext Growth , Presse Financi , Pharnext Sa Stock Exchange , Press Release , Ith Alpha Fr001400gun7 ,

Dementia Treatment: Scientists Find Sodium Selenate as Potential Remedy for Neurodegenerative Condition

Scientists conducted a study that suggests sodium selenate could be a potential dementia treatment capable of slowing brain shrinkage. ....

South Australia , Lucy Vivash , Monash University Department Of Neuroscience , Other Research , National Institute Of Health , Transnational Research , Dementia Treatment , Scientists Find Sodium Selenate , Potential Remedy , Getty Images , Selenate Could , Potential Dementia , Royal Melbourne Hospital , Monash University , Scientists Unveil More Accurate Structure , National Institute ,

PARIS, France, May 12th, 2023, 08:30 am CET – Pharnext SA , an advanced late-clinical stage biopharmaceutical company developing novel therapeutics for neurodegenerative diseases with high. | May 12, 2023 ....

United States , France General , Javier Granda , Fabreguettes Leib , Neurology Service , Spanish Society Of Neurology , Neuromuscular Diseases Group , Euronext Growth Stock Exchange , Spring Meeting , Neuromuscular Diseases Study Group , Spanish Society , Hospital Universitario Central De Asturias , Hospital Universitario De Cabue , Presse Financi , Pharnext Sa Stock Exchange , Press Release , Ith Alpha Fr001400gun7 ,

BrainStorm to Announce First Quarter 2023 Financial Results and Provide a Corporate Update

NEW YORK, May 9, 2023 /PRNewswire/ BrainStorm Cell Therapeutics Inc. , a leading developer of cellular therapies for neurodegenerative diseases, announced today that it will hold a conference. | May 9, 2023 ....

United States , John Mullaly , Stacy Lindborg , Kirk Taylor , Lisa Guiterman , Chaim Lebovits , Brainstorm Cell Therapeutics Inc , Lifesci Advisors , California Institute For Regenerative Medicine , Prnewswire Brainstorm Cell Therapeutics Inc , Drug Administration , National Ms Society , European Medicines Agency , Storm Cell Therapeutics , First Quarter , Chief Executive Officer , Co Chief Executive Officer , Executive Vice President , Chief Medical Officer , Alla Patlis , Interim Chief Financial , Orphan Drug , California Institute , Regenerative Medicine , Harbor Statement , Brainstorm Cell Therapeutics ,

Vigil Neuroscience Launches ALSPAware to Provide Access to No-cost Genetic Testing and Counseling for Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia (ALSP)

– New genetic testing initiative designed to enable improved patient diagnosis of ALSP, a devastating, rare genetic neurodegenerative disease – – Through ALSPAware, individuals and. | May 8, 2023 ....

United States , Sarah Carmody , Ivana Magov , Megan Mcgrath , Sister Hope Foundation , Sciences Corp , Hunter Hope Foundation , Vigil Neuroscience Inc , United Leukodystrophy Foundation , Sciences Company , Exchange Commission , Clinical Laboratory Improvement Amendments , International Organization For Standardization , Exact Sciences Company , Chief Executive Officer , Hope Foundation , Investigational New Drug Application , Exact Sciences Corp , International Organization , Vigil Neuroscience , Annual Report , Nc Stock Exchange , Press Release , Ndividuals Vigl Us92673k1088 ,